Journey Medical Corp reports results for the quarter ended in September - Earnings Summary

Journey Medical

10/11/2022 22:02

* Journey Medical Corp  DERM.OQ  reported a quarterly
adjusted
loss of 57 cents​​ per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was for a
loss of 40 cents per share.
    * Revenue fell 17.8% to $16.12 million from a year ago;
analysts
expected $17.65 million. 
    * Journey Medical Corp's reported EPS for the quarter was a
loss
of 57 cents​.
    * The mean earnings estimate of analysts had fallen by
about 25.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Journey Medical Corp shares had fallen by 6.5% this
quarter and
lost 57.2% so far this year.
    * The company reported a quarterly loss of $10.08 million.
    * Wall Street's median 12-month price target for Journey
Medical
Corp is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.40          -0.57          Missed
 Jun. 30 2022      -0.26          -0.43          Missed
 Mar. 31 2022      -0.31          -0.08          Beat
 Dec. 31 2021      -0.41          -1.64          Missed